Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q) BLOOD CANCER JOURNAL Sekeres, M. A., Swern, A. S., Fenaux, P., Greenberg, P. L., Sanz, G. F., Bennett, J. M., Dreyfus, F., List, A. F., Li, J. S., Sugrue, M. M. 2014; 4: e242

View details for PubMedID 25171203